Novo Holdings A/S, a leading global life sciences investor, today announced that it has agreed to acquire Ellab from EQT. Headquartered in Hillerød, Denmark, Ellab (“Ellab”) provides validation and monitoring solutions and services for biotech and pharmaceutical processes. Its solutions and services measure and document parameters such as temperature, pressure and carbon dioxide, which helps […]
Acquisition of Brain Therapeutics with operations in Greece, Cyprus and the Balkan countries Dusseldorf and Barcelona, March 8th, 2022 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the central nervous system (CNS), today announces the expansion of its business in Southeast Europe through the acquisition of Brain Therapeutics, a CNS-focused marketing and distribution […]
– Phebra takes part ownership of Flexipharm Austrading through share purchase – Builds on Phebra’s Existing UK Distribution Agreement – Strengthens Phebra’s Presence in UK and Europe SYDNEY and BOURNE END, England, Nov. 3, 2021 /PRNewswire/ — Leading Australian pharmaceutical group Phebra Holdings (‘Phebra’) is pleased to announce that it has completed a share purchase agreement with the UK hospital […]
As many countries continue to pass the peak of COVID-19, Masters Speciality Pharma’s Head of Licensing, Sid Masters believes now is a good time to reflect on the challenges, successes and response of the pharmaceutical industry during the pandemic. Sid writes: Over the past few months we have seen Covid-19 wreak havoc by crippling our […]
